Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Anticancer Research|September 4, 2020
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin ExpressionTakeshi Miyao, Hidekazu Koike, Yoshitaka Sekine, et al.
Biochemical and Biophysical Research Communications|April 12, 2015
Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptorHaruo Kato, Yoshitaka Sekine, Yosuke Furuya, et al.
Prostate International|November 14, 2013
Simple method for preventing inguinal hernias after radical retropubic prostatectomyHidekazu Koike, Hiroshi Matsui, Yasuyuki Morikawa, et al.
Prostate International|November 14, 2013
Chlormadinone acetate is effective for hot flush during androgen deprivation therapyHidekazu Koike, Yasuyuki Morikawa, Hiroshi Matsui, et al.
Biochemical and Biophysical Research Communications|March 6, 2012
Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulationYasuyuki Morikawa, Hidekazu Koike, Yoshitaka Sekine, et al.
Anticancer Research|February 26, 2004
Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stageHidekazu Koike, Kazuhiro Suzuki, Tetsuo Satoh, et al.
Prostate International|November 14, 2013
Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancerKazumichi Muramatsu, Hiroshi Matsui, Yoshitaka Sekine, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation TherapyYoshiyuki Miyazawa, Yoshitaka Sekine, Seiji Arai, et al.
Anticancer Research|April 12, 2003
Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarrayHiroshi Matsui, Kazuhiro Suzuki, Masaru Hasumi, et al.
World Journal of Urology|August 21, 2012
Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL rangeKazuto Ito, Mai Miyakubo, Yoshitaka Sekine, et al.
Pageof 9